Bakken K - Search Results

1

Use of dietary supplements and medication among postmenopausal women with vasomotor symptoms.

Waaseth M, Nakling M, Bakken K, Grimsgaard S. Waaseth M, et al. Among authors: bakken k. Climacteric. 2010 Dec;13(6):585-93. doi: 10.3109/13697130903480714. Epub 2009 Dec 29. Climacteric. 2010. PMID: 20039787 Clinical Trial.

2

[Local monitoring center for clozapine (Leponex) treatment].

Bakken K, Bratlid T, Erlandsen C, Lingjaerde O, Nome S. Bakken K, et al. Tidsskr Nor Laegeforen. 1998 Mar 10;118(7):1076-8. Tidsskr Nor Laegeforen. 1998. PMID: 9531833 Norwegian.

3

[Application of gene technology in the diagnosis of familial hypercholesterolemia].

Leren TP, Bakken KS, Rødningen OK, Gundersen KE, Sundvold H, Berg K, Tonstad S, Ose L. Leren TP, et al. Among authors: bakken ks. Tidsskr Nor Laegeforen. 1997 Feb 20;117(5):678-81. Tidsskr Nor Laegeforen. 1997. PMID: 9102960 Norwegian.

4

Molecular genetics of familial hypercholesterolaemia in Norway.

Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rødningen OK, Sundvold H, Ose L, Berg K. Leren TP, et al. Among authors: bakken ks. J Intern Med. 1997 Mar;241(3):185-94. doi: 10.1046/j.1365-2796.1997.78119000.x. J Intern Med. 1997. PMID: 9104431 Free article.

5

Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program.

Leren TP, Manshaus T, Skovholt U, Skodje T, Nossen IE, Teie C, Sørensen S, Bakken KS. Leren TP, et al. Semin Vasc Med. 2004 Feb;4(1):75-85. doi: 10.1055/s-2004-822989. Semin Vasc Med. 2004. PMID: 15199436 Review.

6

Screening for mutations of the apolipoprotein B gene causing hypocholesterolemia.

Leren TP, Bakken KS, Hoel V, Hjermann I, Berg K. Leren TP, et al. Among authors: bakken ks. Hum Genet. 1998 Jan;102(1):44-9. doi: 10.1007/s004390050651. Hum Genet. 1998. PMID: 9490296

7

Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.

Leren TP, Bakken KS, Daum U, Ose L, Berg K, Assmann G, von Eckardstein A. Leren TP, et al. Among authors: bakken ks. J Lipid Res. 1997 Jan;38(1):121-31. J Lipid Res. 1997. PMID: 9034206 Free article.

8

Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress.

Sørensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA. Sørensen S, et al. J Biol Chem. 2006 Jan 6;281(1):468-76. doi: 10.1074/jbc.M507071200. Epub 2005 Oct 28. J Biol Chem. 2006. PMID: 16257961 Free article.

9

Bystander effects, pharmacokinetics, and linker-payload stability of EGFR-targeting antibody-drug conjugates Losatuxizumab vedotin and Depatux-M in glioblastoma models.

Jain S, Griffith JI, Porath KA, Rathi S, Le J, Pasa TI, Decker PA, Gupta SK, Hu Z, Carlson BL, Bakken K, Burgenske DM, Feldsien TM, Lefebvre DR, Vaubel RA, Eckel-Passow JE, Reilly EB, Elmquist WF, Sarkaria JN. Jain S, et al. Among authors: bakken k. Clin Cancer Res. 2024 May 14. doi: 10.1158/1078-0432.CCR-24-0426. Online ahead of print. Clin Cancer Res. 2024. PMID: 38743766

10

Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.

Chen J, Laverty DJ, Talele S, Bale A, Carlson BL, Porath KA, Bakken KK, Burgenske DM, Decker PA, Vaubel RA, Eckel-Passow JE, Bhargava R, Lou Z, Hamerlik P, Harley B, Elmquist WF, Nagel ZD, Gupta SK, Sarkaria JN. Chen J, et al. Among authors: bakken kk. Sci Transl Med. 2024 Feb 14;16(734):eadj5962. doi: 10.1126/scitranslmed.adj5962. Epub 2024 Feb 14. Sci Transl Med. 2024. PMID: 38354228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page